Trump's Latest Name For GLP-1s Has Doctors And Patients Raising An Important Concern

Filed 21h ago · Via HuffPost · The Buffoon Desk

THIS STORY IS SCORED

Myst

Kevin MacLeod · incompetech.com · CC BY 4.0

Photo: DJTechYT · CC BY-SA 4.0 · via Wikimedia Commons

President Trump has repeatedly referred to GLP-1 medications as ‘fat shots’ or ‘fat drugs’ even as his administration has worked to lower their cost through Medicare and Medicaid, prompting pushback from doctors and patients interviewed by HuffPost. The drugs, originally approved for Type 2 diabetes, are now used for obesity, sleep apnea and reducing heart disease risk, with Gallup polling showing 11 percent of American adults now taking them, up from 3 percent in 2024.

Dr. Eric Burnett, an internal medicine physician, said he's less bothered by Trump's phrasing than by Medicaid's continued failure to cover the medications for most patients who need them. Others quoted called the ‘fat shot’ label fatphobic and said it flattens the drugs' broader medical uses into something resembling a vanity product.

The full dispatch is available from the source below.

✒ FROM THE EDITORIAL DESK

Calling a diabetes and heart-disease drug a ‘fat shot’ is the kind of thing that sounds like a joke at a rally and lands like an insult in a waiting room. The doctors interviewed here aren't even asking for better manners, they're asking why the same administration cheapening the name hasn't gotten Medicaid to pay for the medicine. That's the cheaper trick: talk tough about the drug while leaving the bill for somebody else to figure out.

Source: Read the original at HuffPost → Scored: Myst · Kevin MacLeod · CC BY 4.0

Read it scored.

Every story, every clown, every kazoo — in your pocket. Music plays automatically. Regret is optional.

GET IT ON iOS GET IT ON ANDROID

OR FOLLOW THE DESK ON BLUESKY →